3-methyl-8-[6-(1-methylpyrazol-4-yl)-3-pyridinyl]-1-(1-methylpyrrolidin-3-yl)imidazo[4,5-c]quinolin-2-one
C25H25N7O — CID 118101794
Data last refreshed: (MolForge compound catalog, from PubChem)
About 3-methyl-8-[6-(1-methylpyrazol-4-yl)-3-pyridinyl]-1-(1-methylpyrrolidin-3-yl)imidazo[4,5-c]quinolin-2-one
3-methyl-8-[6-(1-methylpyrazol-4-yl)-3-pyridinyl]-1-(1-methylpyrrolidin-3-yl)imidazo[4,5-c]quinolin-2-one (PubChem CID 118101794) has the molecular formula C25H25N7O and a molecular weight of 439.52 g/mol. Its IUPAC name is 3-methyl-8-[6-(1-methylpyrazol-4-yl)-3-pyridinyl]-1-(1-methylpyrrolidin-3-yl)imidazo[4,5-c]quinolin-2-one.
Molecular Properties
| Compound Name | 3-methyl-8-[6-(1-methylpyrazol-4-yl)-3-pyridinyl]-1-(1-methylpyrrolidin-3-yl)imidazo[4,5-c]quinolin-2-one |
|---|---|
| PubChem CID | 118101794 |
| Molecular Formula | C25H25N7O |
| Molecular Weight | 439.52 g/mol |
| Exact Mass | 439.21 |
| IUPAC Name | 3-methyl-8-[6-(1-methylpyrazol-4-yl)-3-pyridinyl]-1-(1-methylpyrrolidin-3-yl)imidazo[4,5-c]quinolin-2-one |
| SMILES | CN1CCC(n2c(=O)n(C)c3cnc4ccc(-c5ccc(-c6cnn(C)c6)nc5)cc4c32)C1 |
| InChI | InChI=1S/C25H25N7O/c1-29-9-8-19(15-29)32-24-20-10-16(4-7-22(20)27-13-23(24)31(3)25(32)33)17-5-6-21(26-11-17)18-12-28-30(2)14-18/h4-7,10-14,19H,8-9,15H2,1-3H3 |
| InChIKey | MRYXQEWYPNZMLN-UHFFFAOYSA-N |
| XLogP | 3.23 |
| TPSA | 73.77 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 33 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 439.52 |
| LogP ≤ 5 | 3.23 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 118101794 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.